The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 10,837 | 6,020,770 | SH | SOLE | 6,020,770 | 0 | 0 | ||
| ROVER GROUP INC | COM CL A | 77936F103 | 97,123 | 26,463,916 | SH | SOLE | 26,463,916 | 0 | 0 | ||
| REMITLY GLOBAL INC | COM | 75960P104 | 1,200 | 104,805 | SH | SOLE | 104,805 | 0 | 0 | ||
| UIPATH INC | CL A | 90364P105 | 7,724 | 607,673 | SH | SOLE | 607,673 | 0 | 0 | ||
| SNOWFLAKE INC | CL A | 833445109 | 90,665 | 631,633 | SH | SOLE | 631,633 | 0 | 0 | ||